MX2010000533A - Analisis multiplexados de muestras de pruebas. - Google Patents

Analisis multiplexados de muestras de pruebas.

Info

Publication number
MX2010000533A
MX2010000533A MX2010000533A MX2010000533A MX2010000533A MX 2010000533 A MX2010000533 A MX 2010000533A MX 2010000533 A MX2010000533 A MX 2010000533A MX 2010000533 A MX2010000533 A MX 2010000533A MX 2010000533 A MX2010000533 A MX 2010000533A
Authority
MX
Mexico
Prior art keywords
nucleic acid
target
detection
kits
methods
Prior art date
Application number
MX2010000533A
Other languages
English (en)
Spanish (es)
Inventor
Larry Gold
Dominic Zichi
Daniel J Schneider
Bruce Eaton
Dan Nieuwlandt
Marty Stanton
Shashi Gupta
Stephan Kraemer
Original Assignee
Somalogic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40260081&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2010000533(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Somalogic Inc filed Critical Somalogic Inc
Publication of MX2010000533A publication Critical patent/MX2010000533A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6811—Selection methods for production or design of target specific oligonucleotides or binding molecules
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1048—SELEX
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/111—General methods applicable to biologically active non-coding nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/115—Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith ; Nucleic acids binding to non-nucleic acids, e.g. aptamers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/16—Aptamers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/33—Chemical structure of the base
    • C12N2310/334—Modified C
    • C12N2310/3341—5-Methylcytosine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2320/00—Applications; Uses
    • C12N2320/10—Applications; Uses in screening processes
    • C12N2320/13—Applications; Uses in screening processes in a process of directed evolution, e.g. SELEX, acquiring a new function
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2525/00—Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
    • C12Q2525/10—Modifications characterised by
    • C12Q2525/205—Aptamer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2541/00—Reactions characterised by directed evolution
    • C12Q2541/10—Reactions characterised by directed evolution the purpose being the selection or design of target specific nucleic acid binding sequences
    • C12Q2541/101—Selex

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Photometry And Measurement Of Optical Pulse Characteristics (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX2010000533A 2007-07-17 2008-07-17 Analisis multiplexados de muestras de pruebas. MX2010000533A (es)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US95028107P 2007-07-17 2007-07-17
US95029307P 2007-07-17 2007-07-17
US95028307P 2007-07-17 2007-07-17
US3142008P 2008-02-26 2008-02-26
US5159408P 2008-05-08 2008-05-08
PCT/US2008/070386 WO2009012420A1 (en) 2007-07-17 2008-07-17 Multiplexed analyses of test samples

Publications (1)

Publication Number Publication Date
MX2010000533A true MX2010000533A (es) 2010-04-30

Family

ID=40260081

Family Applications (7)

Application Number Title Priority Date Filing Date
MX2010000578A MX2010000578A (es) 2007-07-17 2008-07-17 Metodo para generar aptameros con constantes de disociacion mejoradas.
MX2014005658A MX344253B (es) 2007-07-17 2008-07-17 Metodo para generar aptameros con constantes de disociacion mejoradas.
MX2010000533A MX2010000533A (es) 2007-07-17 2008-07-17 Analisis multiplexados de muestras de pruebas.
MX2016016043A MX375114B (es) 2007-07-17 2008-07-17 Método para generar aptámeros con constantes de disociación mejoradas.
MX2016010844A MX355017B (es) 2007-07-17 2010-01-13 Analisis multiplexados de muestras de pruebas.
MX2014013401A MX341491B (es) 2007-07-17 2010-01-13 Analisis multiplexados de muestras de pruebas.
MX2020009595A MX2020009595A (es) 2007-07-17 2010-01-14 Metodo para generar aptameros con constantes de disociacion mejoradas.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
MX2010000578A MX2010000578A (es) 2007-07-17 2008-07-17 Metodo para generar aptameros con constantes de disociacion mejoradas.
MX2014005658A MX344253B (es) 2007-07-17 2008-07-17 Metodo para generar aptameros con constantes de disociacion mejoradas.

Family Applications After (4)

Application Number Title Priority Date Filing Date
MX2016016043A MX375114B (es) 2007-07-17 2008-07-17 Método para generar aptámeros con constantes de disociación mejoradas.
MX2016010844A MX355017B (es) 2007-07-17 2010-01-13 Analisis multiplexados de muestras de pruebas.
MX2014013401A MX341491B (es) 2007-07-17 2010-01-13 Analisis multiplexados de muestras de pruebas.
MX2020009595A MX2020009595A (es) 2007-07-17 2010-01-14 Metodo para generar aptameros con constantes de disociacion mejoradas.

Country Status (17)

Country Link
US (1) US8409795B2 (enExample)
EP (10) EP2172566B2 (enExample)
JP (11) JP5404620B2 (enExample)
KR (3) KR101634608B1 (enExample)
CN (6) CN101802225B (enExample)
AU (3) AU2008275917B2 (enExample)
CA (4) CA3022666C (enExample)
DK (4) DK2069529T3 (enExample)
ES (6) ES3045958T3 (enExample)
FI (1) FI3284832T3 (enExample)
HR (1) HRP20150382T1 (enExample)
MX (7) MX2010000578A (enExample)
NO (1) NO2933340T3 (enExample)
PL (1) PL2489743T3 (enExample)
PT (2) PT2489743E (enExample)
SI (1) SI2489743T1 (enExample)
WO (3) WO2009012420A1 (enExample)

Families Citing this family (137)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5993279A (ja) * 1982-11-17 1984-05-29 富士通株式会社 ロボツトによるカ−ド，レシ−ト分離取出し方法
US20070166741A1 (en) 1998-12-14 2007-07-19 Somalogic, Incorporated Multiplexed analyses of test samples
US7964356B2 (en) * 2007-01-16 2011-06-21 Somalogic, Inc. Method for generating aptamers with improved off-rates
US7947447B2 (en) 2007-01-16 2011-05-24 Somalogic, Inc. Method for generating aptamers with improved off-rates
US8975026B2 (en) 2007-01-16 2015-03-10 Somalogic, Inc. Method for generating aptamers with improved off-rates
US8404830B2 (en) * 2007-07-17 2013-03-26 Somalogic, Inc. Method for generating aptamers with improved off-rates
MX2010000578A (es) 2007-07-17 2010-04-30 Somalogic Inc Metodo para generar aptameros con constantes de disociacion mejoradas.
US8314052B2 (en) * 2009-03-23 2012-11-20 Base Pair Biotechnologies, Inc. Methods for simultaneous generation of functional ligands
WO2012006632A2 (en) * 2010-07-09 2012-01-12 Somalogic, Inc. Lung cancer biomarkers and uses thereof
US9447461B2 (en) 2009-03-24 2016-09-20 California Institute Of Technology Analysis devices, kits, and related methods for digital quantification of nucleic acids and other analytes
US10196700B2 (en) 2009-03-24 2019-02-05 University Of Chicago Multivolume devices, kits and related methods for quantification and detection of nucleic acids and other analytes
EP2412020B1 (en) 2009-03-24 2020-09-30 University Of Chicago Slip chip device and methods
US9464319B2 (en) 2009-03-24 2016-10-11 California Institute Of Technology Multivolume devices, kits and related methods for quantification of nucleic acids and other analytes
US8569252B2 (en) * 2009-04-15 2013-10-29 Postech Academy-Industry Foundation Nucleolin specific aptamer and use thereof
AU2013203588C1 (en) * 2009-07-09 2016-06-30 Somalogic Operating Co., Inc. Method for generating aptamers with improved off-rates
JP5967687B2 (ja) * 2009-07-17 2016-08-10 Ｎｅｃソリューションイノベータ株式会社 スフィンゴシルホスホリルコリンに結合するアプタマー分子
US8236570B2 (en) 2009-11-03 2012-08-07 Infoscitex Methods for identifying nucleic acid ligands
US8841429B2 (en) * 2009-11-03 2014-09-23 Vivonics, Inc. Nucleic acid ligands against infectious prions
US9453845B2 (en) 2010-02-01 2016-09-27 Cell Signaling Technology, Inc. Mass spectroscopy analysis of mutant polypeptides in biological samples
RU2615143C2 (ru) * 2010-03-24 2017-04-04 Адвирна Самодоставляющие PHKi соединения уменьшенного размера
AU2011240677B2 (en) * 2010-04-12 2015-05-14 Somalogic Operating Co., Inc. 5-position modified pyrimidines and their use
AU2013202528B2 (en) * 2010-04-12 2015-07-30 Somalogic Operating Co., Inc. 5-position modified pyrimidines and their use
CN103429753A (zh) 2010-09-27 2013-12-04 私募蛋白质体公司 间皮瘤生物标记及其用途
US9416360B2 (en) 2010-11-05 2016-08-16 MiRagen Therapeutics, Inc. Base modified oligonucleotides
KR101307616B1 (ko) * 2011-02-08 2013-09-12 경희대학교 산학협력단 Ｐｎａ 앱타머를 이용하여 금속을 분리하는 방법
JP5805788B2 (ja) * 2011-12-28 2015-11-10 シスメックス株式会社 副腎皮質刺激ホルモンと結合する分子およびその利用
WO2013102096A1 (en) 2011-12-30 2013-07-04 Quest Diagnostics Investments Incorporated Aptamers and diagnostic methods for detecting the egf receptor
US9410156B2 (en) 2012-03-28 2016-08-09 Somalogic, Inc. Aptamers to PDGF and VEGF and their use in treating PDGF and VEGF mediated conditions
CN108587867B (zh) * 2012-05-25 2021-12-17 北卡罗来纳-查佩尔山大学 微流体装置、用于试剂的固体支持体和相关方法
AU2013271401B2 (en) * 2012-06-07 2018-04-05 Somalogic Operating Co., Inc. Aptamer-based multiplexed assays
CN102719430B (zh) * 2012-06-13 2013-06-12 湖南大学 一种检测组氨酸标签重组蛋白的核酸适配体分子信标探针及其检测方法
KR101556339B1 (ko) * 2012-07-02 2015-10-13 국립대학법인 울산과학기술대학교 산학협력단 페리오스틴에 대한 압타머 및 이를 포함하는 항암제 조성물
EP2690441A1 (en) * 2012-07-26 2014-01-29 Rheinische Friedrich-Wilhelms-Universität Bonn Method of determining a protein in a sample
CN102912020B (zh) * 2012-10-20 2014-02-19 江南大学 一种测定赭曲霉毒素a的适配体传感器的构建方法
EP4170031A1 (en) 2012-10-23 2023-04-26 Caris Science, Inc. Aptamers and uses thereof
US10942184B2 (en) 2012-10-23 2021-03-09 Caris Science, Inc. Aptamers and uses thereof
WO2014074682A1 (en) 2012-11-07 2014-05-15 Somalogic, Inc. Chronic obstructive pulmonary disease (copd) biomarkers and uses thereof
WO2014100434A1 (en) 2012-12-19 2014-06-26 Caris Science, Inc. Compositions and methods for aptamer screening
SG11201507335QA (en) 2013-03-14 2015-10-29 Somalogic Inc Aptamers that bind to il-6 and their use in treating or diagnosing il-6 mediated conditions
EP2972386B1 (en) 2013-03-15 2018-01-10 Somalogic, Inc. Nonalcoholic fatty liver disease (nafld) and nonalcoholic steatohepatitis (nash) biomarkers and uses thereof
WO2014144744A1 (en) 2013-03-15 2014-09-18 The Trustees Of Columbia University In The City Of New York Aptamer methods and compositions
JP6034261B2 (ja) * 2013-08-02 2016-11-30 日本電信電話株式会社 生体分子検出用チップの製造方法
EP3044334B1 (en) * 2013-09-09 2020-08-12 Somalogic, Inc. Pdgf and vegf aptamers having improved stability and their use in treating pdgf and vegf mediated diseases and disorders
CA2924987C (en) 2013-09-24 2022-08-16 Somalogic, Inc. Multiaptamer target detection
WO2015049356A1 (en) * 2013-10-02 2015-04-09 Tolle Fabian A method of identifying or producing an aptamer
EP3330277A3 (en) 2013-11-21 2018-09-26 Somalogic, Inc. Cytidine-5-carboxamide modified nucleotide compositions and methods related thereto
EP3425090B1 (en) 2014-02-18 2019-10-23 SomaLogic, Inc. Compositions and methods for detecting microorganisms
WO2015164617A1 (en) 2014-04-24 2015-10-29 Somalogic, Inc. Tuberculosis biomarkers in urine and uses thereof
WO2015164616A1 (en) 2014-04-24 2015-10-29 Somalogic, Inc. Biomarkers for detection of tuberculosis
WO2016000216A1 (zh) * 2014-07-01 2016-01-07 深圳迈瑞生物医疗电子股份有限公司 一种全血样本检测方法及血液检测仪
KR102328327B1 (ko) 2014-09-26 2021-11-22 소마로직, 인크. 심혈관 위험 사건 예측 및 이의 용도
KR101849557B1 (ko) * 2014-09-29 2018-04-17 동국대학교 산학협력단 신규 세포 타겟 압타머 제조방법
EP3201353B1 (en) * 2014-10-02 2019-12-25 Rheinische Friedrich-Wilhelms-Universität Bonn A method of identifying or producing an aptamer
KR101719285B1 (ko) * 2014-11-04 2017-03-23 한국과학기술원 표적 물질에 의해 조절되는 핵산 중합효소 활성을 이용한 생체물질의 검출 및 정량 방법
KR102558890B1 (ko) 2014-11-24 2023-07-21 소마로직 오퍼레이팅 컴퍼니, 인코포레이티드 성장 분화 인자 11에 결합하는 핵산 화합물
CN104360077A (zh) * 2014-11-25 2015-02-18 重庆市科学技术研究院 一种用于检测多西环素残留的适配体核酸探针试剂盒、制备方法及其应用
WO2016123058A1 (en) 2015-01-27 2016-08-04 Somalogic, Inc. Biomarkers for detection of tuberculosis risk
US10370669B2 (en) 2015-02-09 2019-08-06 Somalogic, Inc. Nucleic acid compounds for binding growth differentiation factor 8
EP3524681A1 (en) 2015-03-12 2019-08-14 The Regents of The University of Michigan Inhibitors of dek protein and related methods
US20180356419A1 (en) 2015-05-08 2018-12-13 Somalogic, Inc. Biomarkers for detection of tuberculosis risk
JP2018532992A (ja) 2015-09-09 2018-11-08 ソマロジック, インコーポレイテッドSomaLogic, Inc. 個別化薬物治療計画の開発方法、及びプロテオミックプロファイルに基づく標的薬物開発
AU2016341208A1 (en) * 2015-10-20 2018-05-10 Sorrento Therapeutics, Inc. Intracellular delivery compounds
WO2017139254A1 (en) 2016-02-08 2017-08-17 Somalogic, Inc. Nonalcoholic fatty liver disease (nafld) and nonalcoholic steatohepatitis (nash) biomarkers and uses thereof
GB201603789D0 (en) * 2016-03-04 2016-04-20 Apta Biosciences Ltd Oligonucleotides and methods for preparing
JP7203613B2 (ja) 2016-07-01 2023-01-13 ソマロジック オペレーティング カンパニー インコーポレイテッド 修飾ヌクレオシドを含むオリゴヌクレオチド
CN106248767B (zh) * 2016-07-15 2018-12-07 济南大学 一种用于检测癌细胞中h2s的三维纸分析器件的制备方法
CN107663220B (zh) * 2016-07-27 2020-10-02 上海伯豪医学检验所有限公司 修饰碱基、包含修饰碱基的核酸、适配体及其应用
KR20190039788A (ko) * 2016-08-22 2019-04-15 닛산 가가쿠 가부시키가이샤 E-카드헤린 결합형 핵산 앱타머를 사용하는 세포 스캐폴드 재료
US11041849B2 (en) * 2016-12-01 2021-06-22 Aptitude Medical Systems, Inc. Methods and systems for identifying candidate nucleic acid agent
KR101993427B1 (ko) * 2017-04-26 2019-10-01 주식회사 압타머사이언스 백혈구에 선택적으로 결합하는 압타머 및 이의 용도
US11072816B2 (en) 2017-05-03 2021-07-27 The Broad Institute, Inc. Single-cell proteomic assay using aptamers
WO2019113506A1 (en) 2017-12-07 2019-06-13 The Broad Institute, Inc. Methods and compositions for multiplexing single cell and single nuclei sequencing
US10481155B2 (en) * 2018-03-09 2019-11-19 Somalogic, Inc. Proteomic assay using quantum sensors
US11841371B2 (en) 2018-03-13 2023-12-12 The Broad Institute, Inc. Proteomics and spatial patterning using antenna networks
US11231420B2 (en) 2018-04-09 2022-01-25 Aptalogic, Inc. Selection and optimization of aptamers to recognize ebola markers
US20210140977A1 (en) 2018-04-16 2021-05-13 University Of Cape Town A three-protein proteomic biomarker for prospective determination of risk for development of active tuberculosis
US11957695B2 (en) 2018-04-26 2024-04-16 The Broad Institute, Inc. Methods and compositions targeting glucocorticoid signaling for modulating immune responses
AT521238B1 (de) 2018-05-09 2020-02-15 Lifetaq Analytics Gmbh In-situ zellanalyse im zellkultursystem
EP3810563A4 (en) 2018-06-22 2022-03-23 Somalogic, Inc. IMPROVED PROTEOMIC MULTIPLEX TESTS
WO2020037250A2 (en) * 2018-08-17 2020-02-20 The Trustees Of Columbia University In The City Of New York Stem-loop receptor-based field-effect transistor sensor devices target detection for small-molecule under physiological salt concentrations
JP7530901B2 (ja) 2018-09-25 2024-08-08 シーメンス・ヘルスケア・ダイアグノスティックス・インコーポレイテッド 分子トラップを使用して、アッセイからビオチン干渉を取り除く方法および組成物
EP3857226B1 (en) 2018-09-25 2023-11-15 Siemens Healthcare Diagnostics Inc. Methods and compositions for removing biotin interference from assays using conjugated molecular traps
WO2020069569A1 (en) 2018-10-02 2020-04-09 WearOptimo Pty Ltd Actuator system
US12048558B2 (en) 2018-10-02 2024-07-30 WearOptimo Pty Ltd System for determining fluid level in a biological subject
WO2020077236A1 (en) 2018-10-12 2020-04-16 The Broad Institute, Inc. Method for extracting nuclei or whole cells from formalin-fixed paraffin-embedded tissues
WO2020081510A1 (en) 2018-10-15 2020-04-23 Somalogic, Inc. Nucleic acid compounds for binding immunoglobulin g
US12402610B2 (en) 2018-11-09 2025-09-02 The Broad Institute, Inc. Methods and compositions for modulating innate lymphoid cell pathogenic effectors
US12460253B2 (en) 2018-12-04 2025-11-04 Roche Sequencing Solutions, Inc. Spatially oriented quantum barcoding of cellular targets
US11739156B2 (en) 2019-01-06 2023-08-29 The Broad Institute, Inc. Massachusetts Institute of Technology Methods and compositions for overcoming immunosuppression
US20220142948A1 (en) 2019-03-18 2022-05-12 The Broad Institute, Inc. Compositions and methods for modulating metabolic regulators of t cell pathogenicity
CN113826170B (zh) * 2019-05-17 2024-12-27 私募蛋白质体操作有限公司 控制复杂生物基质中的样品间分析物可变性
US20220243178A1 (en) 2019-05-31 2022-08-04 The Broad Institute, Inc. Methods for treating metabolic disorders by targeting adcy5
US11198908B2 (en) 2019-06-17 2021-12-14 Biorchestra Co., Ltd. Method for diagnosis of Alzheimer's disease using microRNA
KR102113078B1 (ko) * 2019-07-05 2020-05-20 광주과학기술원 압타머의 선별 방법
WO2021030627A1 (en) 2019-08-13 2021-02-18 The General Hospital Corporation Methods for predicting outcomes of checkpoint inhibition and treatment thereof
CN110396536A (zh) * 2019-08-14 2019-11-01 东南大学 一种基于分支滚环扩增的外泌体荧光检测传感器
US12421557B2 (en) 2019-08-16 2025-09-23 The Broad Institute, Inc. Methods for predicting outcomes and treating colorectal cancer using a cell atlas
BR112022003666A2 (pt) 2019-09-03 2022-05-24 Somalogic Operating Co Inc Predição de evento de risco cardiovascular e usos da mesma
CN110618265B (zh) * 2019-09-12 2023-04-18 广东省药品检验所（广东省药品质量研究所、广东省口岸药品检验所） 一种沙丁胺醇的可视化检测方法
US12195725B2 (en) 2019-10-03 2025-01-14 Dana-Farber Cancer Institute, Inc. Compositions and methods for modulating and detecting tissue specific TH17 cell pathogenicity
US11981922B2 (en) 2019-10-03 2024-05-14 Dana-Farber Cancer Institute, Inc. Methods and compositions for the modulation of cell interactions and signaling in the tumor microenvironment
US11793787B2 (en) 2019-10-07 2023-10-24 The Broad Institute, Inc. Methods and compositions for enhancing anti-tumor immunity by targeting steroidogenesis
EP4045656A1 (en) 2019-10-16 2022-08-24 SomaLogic Operating Co., Inc. Nucleic acid compounds that bind to retinoic acid-inducible gene i protein
US20230093390A1 (en) * 2019-12-03 2023-03-23 Sung Chun Kim Method for obtaining profile of target molecule population of sample
CN115023615A (zh) 2020-01-10 2022-09-06 私募蛋白质体操作有限公司 确定葡萄糖耐量减低的方法
US12165747B2 (en) 2020-01-23 2024-12-10 The Broad Institute, Inc. Molecular spatial mapping of metastatic tumor microenvironment
MX2022009517A (es) 2020-02-10 2022-09-02 Somalogic Operating Co Inc Biomarcadores de esteatohepatitis no alcoholica (nash) y usos de los mismos.
CN111304202B (zh) * 2020-02-26 2023-03-28 西安交通大学 一种用于识别且增强hmgb1生物学活性的核酸适配子及其应用
CA3177368A1 (en) * 2020-04-22 2021-10-28 Quantum-Si Incorporated Devices and methods for sequencing
CN113624724A (zh) * 2020-05-07 2021-11-09 廖世奇 一种适配体分子信标对靶分子的多元检测分析方法
AU2021275808A1 (en) * 2020-05-18 2022-11-10 Shanghai Polaris Biology Co., Ltd. Microbeads and uses thereof
CN111735869A (zh) * 2020-05-29 2020-10-02 中山大学 一种蛋白质的检测试剂及检测方法
CA3188501A1 (en) 2020-08-07 2022-02-10 Todd Golub Therapeutic targeting of phosphate dysregulation in cancer via the xpr1:kidins220 protein complex
CN116529604A (zh) 2020-10-20 2023-08-01 私募蛋白质体操作有限公司 心血管事件风险预测
KR20230170688A (ko) 2021-04-13 2023-12-19 소마로직 오퍼레이팅 컴퍼니, 인코포레이티드 변형된 뉴클레오사이드
EP4323524A1 (en) 2021-04-14 2024-02-21 SomaLogic Operating Co., Inc. Nucleic acid compounds that bind coronavirus proteins
CA3217457A1 (en) * 2021-05-06 2022-11-10 Spyro Mousses Multitargeting rna immunotherapy compositions
EP4356140A2 (en) 2021-06-15 2024-04-24 SomaLogic Operating Co., Inc. Renal insufficiency prediction and uses thereof
EP4413372A1 (en) 2021-10-07 2024-08-14 SomaLogic Operating Co., Inc. Lung cancer prediction and uses thereof
CN114058613B (zh) * 2021-11-18 2023-10-27 广州血液中心(中国医学科学院输血研究所广州分所、广州器官移植配型中心) 一种大体积、高灵敏度核酸提取方法
CN114295594B (zh) * 2021-12-06 2023-09-19 贵州理工学院 一种基于分子信标筛选三螺旋DNA嵌入剂的“turn on”型荧光传感器
WO2023141248A1 (en) 2022-01-21 2023-07-27 Somalogic Operating Co., Inc. Methods for sample quality assessment
WO2023183873A1 (en) 2022-03-24 2023-09-28 Mensura Health Inc. Aptamers and uses thereof
AU2023259062A1 (en) 2022-04-24 2024-09-12 Somalogic Operating Co., Inc. Methods for sample quality assessment
EP4515249A1 (en) 2022-04-24 2025-03-05 SomaLogic Operating Co., Inc. Methods for sample quality assessment
WO2023211773A1 (en) 2022-04-24 2023-11-02 Somalogic Operating Co., Inc. Methods for sample quality assessment
WO2023211769A1 (en) 2022-04-24 2023-11-02 Somalogic Operating Co., Inc. Methods for sample quality assessment
WO2024015485A1 (en) 2022-07-14 2024-01-18 Somalogic Operating Co., Inc. Methods of assessing dementia risk
CN119173765A (zh) 2022-07-14 2024-12-20 私募蛋白质体操作有限公司 用于样品质量评估的方法
CA3265497A1 (en) 2022-09-23 2024-03-28 Somalogic Operating Co., Inc. METHODS FOR ASSESSING TOBACCO USE STATUS
WO2024192141A1 (en) 2023-03-13 2024-09-19 Dana-Farber Cancer Institute, Inc. Treatment of cancers having a drug-resistant mesenchymal cell state
US20240424107A1 (en) 2023-04-07 2024-12-26 POSTECH Research and Business Development Foundation Preparation of site-specific polypeptide conjugates
WO2025049331A2 (en) * 2023-08-31 2025-03-06 Illumina, Inc. Aptamer detection techniques
WO2025129158A1 (en) 2023-12-15 2025-06-19 The Broad Institute, Inc. Engineered arc delivery vesicles and uses thereof
EP4603584A1 (en) * 2024-02-16 2025-08-20 Leica Microsystems CMS GmbH Affinity reagent, marker and method for analysing a biological sample
WO2025250808A1 (en) 2024-05-29 2025-12-04 The Brigham And Women’S Hospital, Inc. Anti-crispr delivery compositions and methods
CN119804610B (zh) * 2024-12-27 2025-11-07 南京师范大学 一种测定适配体和小分子靶标间相互作用的非变性质谱检测方法

Family Cites Families (98)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
DE3590766C2 (enExample) 1985-03-30 1991-01-10 Marc Genf/Geneve Ch Ballivet
US4753983A (en) 1986-05-07 1988-06-28 Bioprobe International, Inc. Polymeric matrix for affinity chromatography and immobilization of ligands
WO1989006694A1 (en) 1988-01-15 1989-07-27 Trustees Of The University Of Pennsylvania Process for selection of proteinaceous substances which mimic growth-inducing molecules
US5035996A (en) 1989-06-01 1991-07-30 Life Technologies, Inc. Process for controlling contamination of nucleic acid amplification reactions
US20040132067A1 (en) 1990-06-11 2004-07-08 Somalogic, Inc. Systematic evolution of ligands by exponential enrichment: photoselection of nucleic acid ligands and solution selex
US5472841A (en) 1990-06-11 1995-12-05 Nexstar Pharmaceuticals, Inc. Methods for identifying nucleic acid ligands of human neutrophil elastase
US5660985A (en) 1990-06-11 1997-08-26 Nexstar Pharmaceuticals, Inc. High affinity nucleic acid ligands containing modified nucleotides
US5580737A (en) 1990-06-11 1996-12-03 Nexstar Pharmaceuticals, Inc. High-affinity nucleic acid ligands that discriminate between theophylline and caffeine
US5789163A (en) 1990-06-11 1998-08-04 Nexstar Pharmaceuticals, Inc. Enzyme linked oligonucleotide assays (ELONAS)
DE69128350T2 (de) 1990-06-11 1998-03-26 Nexstar Pharmaceuticals Inc Nukleinsäureliganden
US5853984A (en) 1990-06-11 1998-12-29 Nexstar Pharmaceuticals, Inc. Use of nucleic acid ligands in flow cytometry
US5763173A (en) 1990-06-11 1998-06-09 Nexstar Pharmaceuticals, Inc. Nucleic acid ligand inhibitors to DNA polymerases
US5874557A (en) 1990-06-11 1999-02-23 Nexstar Pharmaceuticals, Inc. Nucleic acid ligand inhibitors to DNA polymerases
US6083696A (en) * 1990-06-11 2000-07-04 Nexstar Pharmaceuticals, Inc. Systematic evolution of ligands exponential enrichment: blended selex
US5763177A (en) 1990-06-11 1998-06-09 Nexstar Pharmaceuticals, Inc. Systematic evolution of ligands by exponential enrichment: photoselection of nucleic acid ligands and solution selex
US5693502A (en) 1990-06-11 1997-12-02 Nexstar Pharmaceuticals, Inc. Nucleic acid ligand inhibitors to DNA polymerases
US5567588A (en) 1990-06-11 1996-10-22 University Research Corporation Systematic evolution of ligands by exponential enrichment: Solution SELEX
US6346611B1 (en) 1990-06-11 2002-02-12 Gilead Sciences, Inc. High affinity TGfβ nucleic acid ligands and inhibitors
US5861254A (en) * 1997-01-31 1999-01-19 Nexstar Pharmaceuticals, Inc. Flow cell SELEX
US6716580B2 (en) * 1990-06-11 2004-04-06 Somalogic, Inc. Method for the automated generation of nucleic acid ligands
US5962219A (en) 1990-06-11 1999-10-05 Nexstar Pharmaceuticals, Inc. Systematic evolution of ligands by exponential enrichment: chemi-selex
US5707796A (en) 1990-06-11 1998-01-13 Nexstar Pharmaceuticals, Inc. Method for selecting nucleic acids on the basis of structure
US5496938A (en) 1990-06-11 1996-03-05 Nexstar Pharmaceuticals, Inc. Nucleic acid ligands to HIV-RT and HIV-1 rev
US5459015A (en) 1990-06-11 1995-10-17 Nexstar Pharmaceuticals, Inc. High-affinity RNA ligands of basic fibroblast growth factor
US6232071B1 (en) * 1990-06-11 2001-05-15 Gilead Sciences, Inc. Tenascin-C nucleic acid ligands
US6168778B1 (en) 1990-06-11 2001-01-02 Nexstar Pharmaceuticals, Inc. Vascular endothelial growth factor (VEGF) Nucleic Acid Ligand Complexes
US6030776A (en) * 1990-06-11 2000-02-29 Nexstar Pharmaceuticals, Inc. Parallel SELEX
US5874218A (en) 1990-06-11 1999-02-23 Nexstar Pharmaceuticals, Inc. Method for detecting a target compound in a substance using a nucleic acid ligand
US6001577A (en) 1998-06-08 1999-12-14 Nexstar Pharmaceuticals, Inc. Systematic evolution of ligands by exponential enrichment: photoselection of nucleic acid ligands and solution selex
US5270163A (en) 1990-06-11 1993-12-14 University Research Corporation Methods for identifying nucleic acid ligands
US5705337A (en) 1990-06-11 1998-01-06 Nexstar Pharmaceuticals, Inc. Systematic evolution of ligands by exponential enrichment: chemi-SELEX
US5210015A (en) 1990-08-06 1993-05-11 Hoffman-La Roche Inc. Homogeneous assay system using the nuclease activity of a nucleic acid polymerase
SE501013C2 (sv) 1990-10-01 1994-10-17 Pharmacia Biosensor Ab Förfarande för förbättring av analys med bindning till fast fas
JPH06508022A (ja) 1991-02-21 1994-09-14 ギリアド　サイエンシズ，インコーポレイテッド 生体分子に特異的なアプタマーおよび生産方法
AU2580892A (en) 1991-09-05 1993-04-05 Isis Pharmaceuticals, Inc. Determination of oligonucleotides for therapeutics, diagnostics and research reagents
JP3739785B2 (ja) * 1991-11-26 2006-01-25 アイシス ファーマシューティカルズ，インコーポレイティド 修飾されたピリミジンを含有するオリゴマーを使用する増強された三重らせんおよび二重らせんの成形
US5312730A (en) * 1992-05-27 1994-05-17 Ciba Corning Diagnostics Corp. Immune complex transfer with lypophilic bridge
US5756291A (en) * 1992-08-21 1998-05-26 Gilead Sciences, Inc. Aptamers specific for biomolecules and methods of making
US5985548A (en) 1993-02-04 1999-11-16 E. I. Du Pont De Nemours And Company Amplification of assay reporters by nucleic acid replication
US5428149A (en) 1993-06-14 1995-06-27 Washington State University Research Foundation Method for palladium catalyzed carbon-carbon coulping and products
US5719273A (en) 1993-06-14 1998-02-17 Nexstar Pharmaceuticals, Inc. Palladium catalyzed nucleoside modifications methods using nucleophiles and carbon monoxide
US5580972A (en) 1993-06-14 1996-12-03 Nexstar Pharmaceuticals, Inc. Purine nucleoside modifications by palladium catalyzed methods
US5998142A (en) 1993-09-08 1999-12-07 Nexstar Pharmaceuticals, Inc. Systematic evolution of ligands by exponential enrichment: chemi-SELEX
EP1793006A3 (en) 1993-09-08 2007-08-22 Gilead Sciences, Inc. Nucleic acid ligands and improved methods for producing the same
DE69435048T2 (de) * 1993-09-17 2008-10-02 Somalogic, Inc., Boulder Systematische evolution von liganden durch exponentielle anreicherung: fotoselektion von nukleinsäureliganden
US6458539B1 (en) * 1993-09-17 2002-10-01 Somalogic, Inc. Photoselection of nucleic acid ligands
US5925517A (en) 1993-11-12 1999-07-20 The Public Health Research Institute Of The City Of New York, Inc. Detectably labeled dual conformation oligonucleotide probes, assays and kits
US5610287A (en) 1993-12-06 1997-03-11 Molecular Tool, Inc. Method for immobilizing nucleic acid molecules
JP4899014B2 (ja) * 1995-06-02 2012-03-21 イーシー・テクノロジー・エルエルシー 求核試薬および一酸化炭素を用いるパラジウム触媒ヌクレオシド修飾方法
US6183967B1 (en) 1995-06-07 2001-02-06 Nexstar Pharmaceuticals Nucleic acid ligand inhibitors to DNA polymerases
DE69638318D1 (de) 1995-06-07 2011-02-17 Gilead Sciences Inc Nukleinsäureliganden, die an DNA-Polymerasen binden und diese inhibieren
US5737498A (en) 1995-07-11 1998-04-07 Beckman Instruments, Inc. Process automation method and apparatus
KR19990067080A (ko) * 1995-10-27 1999-08-16 엘리엇 알. 램버그 특정 뉴클레오티드 서열의 검출방법 및 조성물
US5727498A (en) * 1996-02-13 1998-03-17 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Retractable visual indicator assembly
US5945527A (en) * 1996-05-30 1999-08-31 Nexstar Pharmaceuticals, Inc. Palladium catalyzed nucleoside modification methods using nucleophiles and carbon monoxide
US5866336A (en) 1996-07-16 1999-02-02 Oncor, Inc. Nucleic acid amplification oligonucleotides with molecular energy transfer labels and methods based thereon
US6051698A (en) 1997-06-06 2000-04-18 Janjic; Nebojsa Vascular endothelial growth factor (VEGF) nucleic acid ligand complexes
US6426335B1 (en) 1997-10-17 2002-07-30 Gilead Sciences, Inc. Vascular endothelial growth factor (VEGF) nucleic acid ligand complexes
US6235471B1 (en) 1997-04-04 2001-05-22 Caliper Technologies Corp. Closed-loop biochemical analyzers
WO1999027133A1 (en) 1997-11-26 1999-06-03 Medical Research Council Improved selex procedure and an anti-cd4 aptamer
US20070166741A1 (en) * 1998-12-14 2007-07-19 Somalogic, Incorporated Multiplexed analyses of test samples
US5989823A (en) 1998-09-18 1999-11-23 Nexstar Pharmaceuticals, Inc. Homogeneous detection of a target through nucleic acid ligand-ligand beacon interaction
US6261783B1 (en) 1997-12-15 2001-07-17 Gilead Sciences, Inc. Homogeneous detection of a target through nucleic acid ligand-ligand beacon interaction
WO2003070984A1 (en) * 2002-02-15 2003-08-28 Somalogic, Inc. Methods and reagents for detecting target binding by nucleic acid ligands
US6242246B1 (en) 1997-12-15 2001-06-05 Somalogic, Inc. Nucleic acid ligand diagnostic Biochip
US6175001B1 (en) * 1998-10-16 2001-01-16 The Scripps Research Institute Functionalized pyrimidine nucleosides and nucleotides and DNA's incorporating same
US20030054360A1 (en) 1999-01-19 2003-03-20 Larry Gold Method and apparatus for the automated generation of nucleic acid ligands
US6329145B1 (en) * 1999-02-09 2001-12-11 Gilead Science, Inc. Determining non-nucleic acid molecule binding to target by competition with nucleic acid ligand
US6376190B1 (en) 2000-09-22 2002-04-23 Somalogic, Inc. Modified SELEX processes without purified protein
WO2002033116A2 (en) * 2000-10-16 2002-04-25 Gilead Sciences, Inc. Nucleic acid ligands to the prostate specific membrane antigen
WO2002044726A1 (fr) * 2000-12-01 2002-06-06 International Reagents Corporation Procede de mesure ultrarapide et ultrasensible
WO2003014369A1 (en) 2001-08-09 2003-02-20 Somalogic, Inc. Nucleic acid ligands with intramolecular duplexes
US20030219801A1 (en) * 2002-03-06 2003-11-27 Affymetrix, Inc. Aptamer base technique for ligand identification
WO2003078623A1 (en) * 2002-03-19 2003-09-25 Fujitsu Limited Functional molecule and process for producing the same
US20030228603A1 (en) * 2002-04-05 2003-12-11 Cload Sharon T. Compositions selective for caffeine or aspartame and methods of using same
US7767803B2 (en) * 2002-06-18 2010-08-03 Archemix Corp. Stabilized aptamers to PSMA and their use as prostate cancer therapeutics
DE10241938A1 (de) 2002-09-10 2004-03-25 Noxxon Pharma Ag Verfahren zur Selektion von Nukleinsäureliganden
CA2407825A1 (en) 2002-10-11 2004-04-11 Andrew J. Simmonds Trap-tagging: a novel method for the identification and purification of rna-protein complexes
JP2004307464A (ja) * 2002-10-23 2004-11-04 Sankyo Co Ltd 糖部ｓ型配座の新規人工核酸
GB0226374D0 (en) * 2002-11-12 2002-12-18 Isis Innovation Ligands
CA2513072A1 (en) * 2003-01-09 2004-07-29 Invitrogen Corporation Cellular delivery and activation polypeptide-nucleic acid complexes
US20040235053A1 (en) * 2003-03-28 2004-11-25 The Regents Of The University Of California Preparation and application of encoded bead aggregates in combinatorial chemistry
US7672786B2 (en) 2003-07-02 2010-03-02 Sergey Krylov Non-equilibrium capillary electrophoresis of equilibrium mixtures (NECEEM)—based methods for drug and diagnostic development
NZ545873A (en) * 2003-08-11 2009-05-31 Monogram Biosciences Inc Detecting and profiling molecular complexes
KR100540509B1 (ko) * 2004-01-07 2006-01-11 학교법인 포항공과대학교 수화젤레이터로 사용되는 2'-데옥시우리딘 유도체
US20050227225A1 (en) * 2004-04-07 2005-10-13 Roche Molecular Systems, Inc. Stabilization of biomolecules in samples
JP4839051B2 (ja) * 2004-10-08 2011-12-14 シスメックス株式会社 核酸プローブを用いる被検物質の検出方法
EP1863828A4 (en) * 2005-03-07 2010-10-13 Archemix Corp STABILIZED APTAMERS FOR PSMA AND THEIR USE AS PROSTATE ACID THERAPEUTICS
JP4368412B2 (ja) * 2005-06-24 2009-11-18 マグ エアロスペース インダストリーズ インコーポレイテッド 軽度汚水インターフェイスバルブ装置および方法
CA2613482A1 (en) * 2005-07-01 2007-02-15 Arbor Vita Corporation Methods and compositions for diagnosis and treatment of influenza
EP1915466B1 (en) * 2005-08-19 2010-11-24 Nanosphere, Inc. Methods for preparing hybrid substrates comprising dna and antibodies and uses thereof
ES2538038T3 (es) * 2006-01-17 2015-06-16 Somalogic, Inc. Análisis multiplexado de muestras de ensayo
AU2007337810B2 (en) * 2006-12-22 2014-02-13 Archemix Corp. Materials and methods for the generation of transcripts comprising modified nucleotides
MX2009007794A (es) * 2007-01-23 2009-08-17 Jostens Inc Metodo y sistema para crear una salida personalizada.
MX2010000578A (es) 2007-07-17 2010-04-30 Somalogic Inc Metodo para generar aptameros con constantes de disociacion mejoradas.
JP2013220095A (ja) * 2012-04-12 2013-10-28 Toyohiro Fujita 苗床
JP2018078250A (ja) 2016-11-11 2018-05-17 株式会社ニューフレアテクノロジー マルチ荷電粒子ビーム描画装置

Also Published As

Publication number Publication date
NO2933340T3 (enExample) 2018-02-03
ES2537322T3 (es) 2015-06-05
JP5956404B2 (ja) 2016-07-27
JP2010533499A (ja) 2010-10-28
AU2008275917A2 (en) 2010-04-29
AU2008275917A1 (en) 2009-01-22
KR101656240B1 (ko) 2016-09-09
HK1174366A1 (en) 2013-06-07
AU2008275915B2 (en) 2013-07-11
JP6491610B2 (ja) 2019-03-27
EP4056711C0 (en) 2025-09-03
MX2020009595A (es) 2020-10-07
EP2069496A1 (en) 2009-06-17
ES2647587T3 (es) 2017-12-22
EP2069496A4 (en) 2010-01-27
MX2010000578A (es) 2010-04-30
EP2489743A2 (en) 2012-08-22
JP7303244B2 (ja) 2023-07-04
PT2172566E (pt) 2015-06-23
CN101802225A (zh) 2010-08-11
CN101809167B (zh) 2015-04-01
CA2696431A1 (en) 2009-01-22
CN101802225B (zh) 2013-10-30
AU2008275917B2 (en) 2014-08-21
HK1246368A1 (en) 2018-09-07
CA3022666A1 (en) 2009-01-22
DK2172566T3 (en) 2015-05-04
JP2015062416A (ja) 2015-04-09
JP5938080B2 (ja) 2016-06-22
JP2016122014A (ja) 2016-07-07
DK3284832T5 (da) 2024-10-07
CN107090457A (zh) 2017-08-25
EP2076613A1 (en) 2009-07-08
EP2069529A2 (en) 2009-06-17
EP2069529A4 (en) 2009-12-30
EP2336314A1 (en) 2011-06-22
JP2019039929A (ja) 2019-03-14
DK2172566T4 (da) 2022-06-13
EP3284832B1 (en) 2023-06-07
EP2489743B1 (en) 2015-01-07
HK1133046A1 (en) 2010-03-12
CN101809167A (zh) 2010-08-18
EP2076613B1 (en) 2016-09-07
JP5684568B2 (ja) 2015-03-11
CA2696431C (en) 2021-01-05
EP2069529B1 (en) 2013-01-09
JP7755619B2 (ja) 2025-10-16
EP2076613A4 (en) 2012-11-28
MX375114B (es) 2025-03-06
SI2489743T1 (sl) 2015-04-30
EP4056711B1 (en) 2025-09-03
AU2008276001A2 (en) 2010-06-03
JP2020078311A (ja) 2020-05-28
DK2489743T3 (en) 2015-03-02
EP2172566B1 (en) 2015-03-04
EP3284832A3 (en) 2018-03-07
ES2537322T5 (es) 2022-09-12
HK1141839A1 (en) 2010-11-19
JP2016171810A (ja) 2016-09-29
WO2009012420A1 (en) 2009-01-22
CN103627792A (zh) 2014-03-12
JP5404620B2 (ja) 2014-02-05
JP6407195B2 (ja) 2018-10-17
KR20100058485A (ko) 2010-06-03
CA2693453A1 (en) 2009-01-22
JP2014050398A (ja) 2014-03-20
JP2010533872A (ja) 2010-10-28
EP2172566B2 (en) 2022-05-18
US8409795B2 (en) 2013-04-02
EP2933340B1 (en) 2017-09-06
PT2489743E (pt) 2015-04-09
JP2019004901A (ja) 2019-01-17
MX355017B (es) 2018-04-02
ES3045958T3 (en) 2025-12-01
ES2533711T3 (es) 2015-04-14
AU2008276001A9 (en) 2010-06-10
CA2693448A1 (en) 2009-01-22
MX341491B (es) 2016-08-23
JP2023116788A (ja) 2023-08-22
KR101634608B1 (ko) 2016-06-29
CN118064441A (zh) 2024-05-24
HRP20150382T1 (hr) 2015-05-08
WO2009012410A1 (en) 2009-01-22
PL2489743T3 (pl) 2015-06-30
EP2626436A2 (en) 2013-08-14
CA3022666C (en) 2022-04-19
CN104593373A (zh) 2015-05-06
HK1132012A1 (zh) 2010-02-12
FI3284832T3 (fi) 2023-08-01
KR20100044787A (ko) 2010-04-30
WO2009012418A3 (en) 2009-03-05
EP4056711A1 (en) 2022-09-14
EP3284832A2 (en) 2018-02-21
ES2951068T3 (es) 2023-10-17
DK2069529T3 (da) 2013-04-15
AU2008275915A1 (en) 2009-01-22
EP2626436A3 (en) 2013-10-16
MX344253B (es) 2016-12-09
EP2172566A1 (en) 2010-04-07
EP2933340A1 (en) 2015-10-21
DK3284832T3 (da) 2023-07-31
WO2009012418A2 (en) 2009-01-22
HK1213020A1 (en) 2016-06-24
KR20160108584A (ko) 2016-09-19
AU2008275915A2 (en) 2010-04-22
KR101747665B1 (ko) 2017-06-15
CA2693453C (en) 2018-12-11
JP2021129577A (ja) 2021-09-09
ES2604764T3 (es) 2017-03-09
US20090098549A1 (en) 2009-04-16
AU2008276001A1 (en) 2009-01-22
EP2489743A3 (en) 2012-11-21

Similar Documents

Publication Publication Date Title
MX341491B (es) Analisis multiplexados de muestras de pruebas.
CA2873099C (en) Aptamer-based multiplexed assays
TW200801203A (en) Multiplexed analyses of test samples
ATE541054T1 (de) Bio-barcode erkennung für zielmoleküle
ATE556030T1 (de) Ultrasensitiver nachweis von analyten
WO2007140291A3 (en) Expression quantification using mass spectrometry
WO2006079049A3 (en) Methods and compositions for increased dynamic range detection of nucleic acid molecules
DK2132339T3 (da) Fremgangsmåde til detektering af en analyt i en biologisk matrix
DE602005013225D1 (de) Aptamer-nanopartikelkonjugate und verwendungsverfahren zur detektion von zielanalyten
WO2009074983A3 (en) Assay for detecting circulating free nucleic acids
EP2344679A4 (en) KITS AND DEVICES FOR DETECTING ANALYTES
WO2007024840A3 (en) Method of quantitating nucleic acids by flow cytometry microparticle-based array
WO2007133704A3 (en) A non-nucleic acid based biobarcode assay for detection of biological materials
ATE431854T1 (de) Auf bio-barcodes beruhender nachweis von zielanalyten
WO2006078660A3 (en) Nucleic acid enzyme ligation sensor
BRPI0610092B8 (pt) métodos para a detecção de um analito e de um ácido nucleico em uma amostra, e de sintetização de uma molécula de ácido nucleico ou de análogo de ácido nucleico, kit reagente, uso do mesmo, molécula de ácido nucleico ou de análogo de ácido nucleico e produto associado
WO2020037130A8 (en) Droplet arrays for detection and quantification of analytes
BR112019007081A2 (pt) sistema de análise e método para testagem de uma amostra
TW200745551A (en) Device and methods for detecting and quantifying one or more target agents
WO2008151207A3 (en) Expression quantification using mass spectrometry
BR112022011676A2 (pt) Kit para detectar um analito de interesse em uma pluralidade de amostras líquidas biológicas, método para detectá-lo e /ou quantificá-lo e cartucho para realizar tal método
Chen et al. Target-protecting dumbbell molecular probe against exonucleases digestion for sensitive detection of ATP and streptavidin
WO2010006201A3 (en) Methods of reducing non-specific interaction in metal nanoparticle assays
Hong et al. Detection and quantification of the Bcr/Abl chimeric protein on biochips using LDI-TOF MS
CY1115062T1 (el) Μεθοδος μεμβρανικου προσδιορισμου

Legal Events

Date Code Title Description
FG Grant or registration